COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 1649: Articles 16481-16490  | Next

Background rates of hospitalizations and emergency department visits for selected thromboembolic and coagulation disorders in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
Nasreen, S., Calzavara, A., Sundaram, M., MacDonald, S. E., Righolt, C., Pai, M., Field, T., Zhou, L. W., Wilson, S., Kwong, J.
10.1101/2021.04.02.21254856 — Posted: 2021-04-04
Controlling the pandemic during the SARS-CoV-2 vaccination rollout: a modeling study
Viana, J., van Dorp, C. H., Nunes, A., Gomes, M. C., van Boven, M., Kretzschmar, M. E., Veldhoen, M., Rozhnova, G.
10.1101/2021.03.24.21254188 — Posted: 2021-04-04
Comparison of post-COVID depression and major depressive disorder
Perlis, R. H., Santillana, M., Ognyanova, K., Green, J., Druckman, J. N., Lazer, D., Baum, M. A.
10.1101/2021.03.26.21254425 — Posted: 2021-04-04
Situation of COVID-19 in Brazil: An analysis via growth models as implemented in the ModInterv system for monitoring the pandemic
Vasconcelos, G. L., Duarte-Filho, G. C., Brum, A. A., Ospina, R., Almeida, F. . A. G., Macedo, A. M. S.
10.1101/2021.03.29.21254542 — Posted: 2021-04-04
Using PARIHS framework to design a community-based COVID-19 intervention in rural Ghana
Frimpong, S., Seidu, M., Hilton, S. K.
10.1101/2021.03.30.21254353 — Posted: 2021-04-04
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Danese, E., Montagnana, M., Salvagno, G. L., Gelati, M., Peserico, D., Pighi, L., De Nitto, S., Henry, B. M., Porru, S., Lippi, G.
10.1101/2021.03.19.21253989 — Posted: 2021-04-04
A Vaccination Simulator for COVID-19: Effective and Sterilizing Immunization Cases.
Karabay, A., Kuzdeuov, A., Lewis, M., Varol, A. H.
10.1101/2021.03.28.21254468 — Posted: 2021-04-04
Estimates and determinants of SARS-CoV-2 seroprevalence and infection fatality ratio using latent class analysis: the population-based Tirschenreuth study in the hardest-hit German county in spring 2020
Wagner, R., Peterhoff, D., Beileke, S., Guenther, F., Berr, M., Einhauser, S., Schuetz, A., Niller, H.-H., Steininger, P., Knoell, A., Tenbusch, M., Maier, C., Korn, K., Stark, K., Gessner, A., Burkhardt, R., Kabesch, M., Schedl, H., Kuechenhoff, H., Pfahlberg, A. B., Heid, I., Gefeller, O., Ueberla, K.
10.1101/2021.03.29.21254343 — Posted: 2021-04-04
COVIDOUTCOME - Estimating COVID Severity Based on Mutation Signatures in the SARS-CoV-2 Genome
Nagy, A., Ligeti, B., Szebeni, J., Pongor, S., Gyorffy, B.
10.1101/2021.04.01.438063 — Posted: 2021-04-02
Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors
Acharya, A., Pandey, K., Thurman, M., Klug, E., Trivedi, J., Lorson, C. L., Singh, K., Byrareddy, S. N.
10.1101/2021.04.02.438204 — Posted: 2021-04-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).